MedPath

The Chinese University of Hong Kong

The Chinese University of Hong Kong logo
🇨🇳China
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.cuhk.edu.hk

Low-magnitude High-frequency Vibration Study on Fracture Rate in Community Elderly

Phase 2
Completed
Conditions
Fractures
Interventions
Device: Low-magnitude high-frequency vibration treatment
First Posted Date
2009-09-09
Last Posted Date
2012-04-24
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
704
Registration Number
NCT00973167
Locations
🇨🇳

Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, China

The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition

Phase 4
Completed
Conditions
Cardiovascular Disease
Renal Failure
ESRD
Interventions
Other: double-chamber bag Stay-Safe Balance system
Other: glucose-based dialysis solution
First Posted Date
2009-08-27
Last Posted Date
2014-09-08
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
68
Registration Number
NCT00966615
Locations
🇭🇰

Department of Medicine & Therapeutics, Prince of Wales Hospital, Sha Tin, Hong Kong

Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study

Conditions
Epilepsy
Interventions
First Posted Date
2009-08-11
Last Posted Date
2009-08-11
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
50
Registration Number
NCT00956696
Locations
🇭🇰

Prince of Wales Hospital, Hong Kong, Hong Kong

Gastric Functions & Proton Pump Inhibitor( PPI) Study

Phase 4
Completed
Conditions
Functional Dyspepsia
Interventions
Drug: Placebo
First Posted Date
2009-08-04
Last Posted Date
2019-02-01
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
155
Registration Number
NCT00951431
Locations
🇭🇰

Prince of Wales Hospital, Hong Kong, Hong Kong

PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)

Not Applicable
Completed
Conditions
Diabetes
Interventions
Behavioral: Usual Care
Behavioral: Patient Peer Support and Empowerment
First Posted Date
2009-08-03
Last Posted Date
2015-08-25
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
632
Registration Number
NCT00950716
Locations
🇨🇳

Asia Diabetes Foundation, Hong Kong, China

Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma

Completed
Conditions
Hepatitis B Virus
First Posted Date
2009-06-03
Last Posted Date
2009-06-03
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
1018
Registration Number
NCT00912847

A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy

Not Applicable
Terminated
Conditions
Diabetes Mellitus
Chronic Kidney Disease
Anemia
Interventions
First Posted Date
2009-05-22
Last Posted Date
2009-05-22
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
16
Registration Number
NCT00907608
Locations
🇨🇳

Prince of Wales Hospital, Hong Kong, China

The Chinese University of Hong Kong Early Arthritis Study

Not Applicable
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2009-05-14
Last Posted Date
2012-08-02
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
40
Registration Number
NCT00901550
Locations
🇨🇳

The Prince of Wales Hospital, Hong Kong, China

🇨🇳

Prince of Wales Hospital, Hong Kong, China

🇨🇳

Department of Medicine and Therapeutics, Hong Kong, China

Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Device: Electroacupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))
Device: Sham acupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))
First Posted Date
2009-05-13
Last Posted Date
2009-07-02
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
42
Registration Number
NCT00900965
Locations
🇨🇳

The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China

Aliskiren for Immunoglobulin A (IgA) Nephropathy

Phase 3
Completed
Conditions
IgA Nephropathy
Interventions
Drug: Placebo
First Posted Date
2009-03-27
Last Posted Date
2012-12-04
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
22
Registration Number
NCT00870493
Locations
🇭🇰

Prince of Wales Hospital, Shatin, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath